← FDA Drug Approvals (Drugs@FDA)

GABAPENTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PAI HOLDINGS PHARM · Approved 2019-12-03

Drug application

FDA Application #

ANDA211330

Application type

Abbreviated New Drug Application (Generic)

Brand name

GABAPENTIN

Generic name

GABAPENTIN

Active ingredients

GABAPENTIN

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

PAI HOLDINGS PHARM

Manufacturer

American Health Packaging

First approval

2019-12-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown